This study is aimed to collect the following Serbia-specific epidemiology data on hypercholesterolemia: patents characteristics, patients' management/treatment and physicians' standard practice. In addition, the aim is to determine the proportion of patients on lipid-lowering pharmacological treatment who have reached the LDL-C and HDL-C treatment goals.
Study Type
OBSERVATIONAL
Enrollment
330
Research Site
Belgrade, Serbia
Research Site
Čačak, Serbia
Research Site
Kamenitz, Serbia
Research Site
Kragujevac, Serbia
Proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines
Time frame: 24 weeks
Proportion of patients on lipid-lowering pharmacological treatment reaching the non HDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines;
Time frame: 24 weeks
Physicians' standard practice in managing patients with hypercholesterolemia (by using physicians' questionnaire);
Time frame: 24 weeks
Local epidemiological date on patients with hypercholesterolemia (Demographic Data; Hypercholesterolemia management data: treatment, treatment changes)
Time frame: 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Niš, Serbia
Research Site
Niška Banja, Serbia
Research Site
Pančevo, Serbia
Research Site
Požarevac, Serbia
Research Site
Sombor, Serbia
Research Site
Užice, Serbia